Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.
about
Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcomeMolecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancersUpdate on thyroid cancer treatment.Anaplastic thyroid carcinoma initially presented with abdominal cutaneous mass and hyperthyroidism.Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy.Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight casesAnaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.Results of combined treatment of anaplastic thyroid carcinoma (ATC)Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.Anaplastic giant cell thyroid carcinoma.RhoB upregulation leads to either apoptosis or cytostasis through differential target selection.Approach to the patient with anaplastic thyroid carcinoma.A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerA cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.Poorly differentiated and anaplastic thyroid cancer.Aggressive multimodal approach for anaplastic thyroid cancer and long-term survival.Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivoAnaplastic Thyroid Carcinoma, Version 2.2015.The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutationsThe role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer.Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.Targeting of slug sensitizes anaplastic thyroid carcinoma SW1736 cells to doxorubicin via PUMA upregulation.Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancerLenvatinib for Anaplastic Thyroid Cancer.Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells.Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.Evolving molecularly targeted therapies for advanced-stage thyroid cancers.Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
P2860
Q33355378-39BEF53E-B912-4F68-9705-76C97C2CE728Q33691759-B7BA7CE3-484A-47F0-97FB-EF90BB1537A3Q34035391-95079E82-9884-40F3-AE5D-F2BAD90E77FFQ34123724-7FAB4B6D-CE8E-4157-9C68-8AFF99FCFB67Q34310219-27BEBF9E-B120-46A5-BC56-9B5C038F534FQ34385082-659ED345-0EB0-4BB0-80C1-5CE5E052338AQ34450398-2AF9C56D-7116-4601-A684-DC512FA2E938Q34946913-6A4EE652-4D2A-4E57-A70E-AAA0771BECACQ35000792-E9D01E45-0951-4E6F-A50E-D00E257D37D4Q35025521-C0257ED5-15A1-469F-8AA2-7AFEDDBBD1F0Q35029319-DFF1237F-653A-4D70-9244-923AD68CBF8FQ35104726-F87F1FAB-76EB-4AC4-890B-91543D6EFB58Q35370655-8C6A404B-5BEA-4149-83F2-7DDD5AF5EC07Q35560562-4AD0C479-BD82-4059-B61E-0712CF0B999AQ35669034-53798206-51B6-4816-A7F6-494884D4960BQ35864072-596EB98F-19C7-4AAD-A551-5524CF9F89ADQ36013613-A2F8F635-2B2C-4769-A9DE-0C8404895D06Q36027160-A0982742-7FD6-4E24-BD2C-7BE5B9829D36Q36134835-7429A0A9-50CA-4877-ABB8-149DC7C69C17Q36201492-17E7096B-B778-4505-B653-810DE6750382Q36282782-AE0EC511-A2D8-492B-B04D-C4735C6B6F92Q36493228-E634A0B9-A979-497D-AEEB-AEB1D65D8BCCQ36692105-03C40072-FF58-44DA-B6CD-0F71FF6E8AC7Q36885846-BFA4B4DF-2E77-4A83-A1A3-E9AEC86B8136Q37057434-9B3B5CFD-549F-4B1C-9318-DD1167B96396Q37179204-626D482D-AB6B-4B44-9C4F-D6B82363DA4FQ37199459-946D158F-86B0-4B11-8C01-BD5902484C5DQ37209593-B28E169E-93BF-4032-BA38-68D9FAB0502DQ37286038-EF73A642-06DA-497F-9CD5-9EAD6661AD85Q37411411-417D4F19-1BD8-4799-80D5-F3F765AF7551Q37526750-9CD3A420-7D47-4D9C-B1CF-CFD8B6799BE3Q37526802-C1676A40-EA07-43F4-9A2A-D48A4B70852CQ37672425-7C0A3B05-60A9-43FD-9B32-8EFD34306FD5Q38217116-35D5A9CB-EC61-477C-AC1E-4032515C918EQ38563654-DFAB94A7-EA18-4CA7-AC27-304D4488FF8EQ38657760-AC11573F-1CBE-436F-AB83-F8A33E9253C1Q38705383-69061113-1580-48E1-A907-4E26AA2A2430Q38754489-952F4465-600B-4D17-B7FB-7EF9EEA61740Q38762992-299D32F5-2544-4053-A773-9C7D00D785D3Q38798863-92E32E8C-67D5-448B-A309-7973C14A25E7
P2860
Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@ast
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@en
Treatment of anaplastic thyroi ...... cer Health Intervention Trials
@nl
type
label
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@ast
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@en
Treatment of anaplastic thyroi ...... cer Health Intervention Trials
@nl
prefLabel
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@ast
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@en
Treatment of anaplastic thyroi ...... cer Health Intervention Trials
@nl
P2093
P356
P1433
P1476
Treatment of anaplastic thyroi ...... ention Trials (CATCHIT) Group.
@en
P2093
P304
P356
10.1089/THY.2000.10.587
P577
2000-07-01T00:00:00Z